Sanguine Revenue and Competitors

Location

$6.2M

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • Sanguine's estimated annual revenue is currently $29.8M per year.(i)
  • Sanguine's estimated revenue per employee is $193,750
  • Sanguine's total funding is $6.2M.

Employee Data

  • Sanguine has 154 Employees.(i)
  • Sanguine grew their employee count by 0% last year.

Sanguine's People

NameTitleEmail/Phone
1
Co-Founder, CEOReveal Email/Phone
2
VP, OperationsReveal Email/Phone
3
VP, Head Human ResourcesReveal Email/Phone
4
VP Marketing and Demand GenerationReveal Email/Phone
5
VP OperationsReveal Email/Phone
6
Chief Product OfficerReveal Email/Phone
7
Director, People OperationsReveal Email/Phone
8
Associate Director, Project ManagementReveal Email/Phone
9
Chief Financial OfficerReveal Email/Phone
10
Sr. Director Product MarketingReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$4.4M57-8%$53MN/A
#2
$21.2M137-26%$110MN/A
#3
$0.9M60%N/AN/A
#4
$2.3M1515%N/AN/A
#5
$1.6M10-17%N/AN/A
#6
$0.7M950%N/AN/A
#7
$11.5M74-12%N/AN/A
#8
$0.4M27510%$236.7MN/A
#9
$4M51-74%$160MN/A
#10
$2.3M1515%N/AN/A
Add Company

What Is Sanguine?

We are the missing link in clinical trials, connecting patients and researchers seamlessly and conveniently using a mobile health platform to advance medical research. We believe it should be easy for patients to contribute to the advancement of research for medical conditions that matter most to them, regardless of their location or ability to travel. Our mobile staff covers the US, Canada and parts of Europe. Each staff member is trained on study specific protocols and carries the credentials necessary to conduct clinical trial procedures in the patient's home.

keywords:N/A

$6.2M

Total Funding

154

Number of Employees

$29.8M

Revenue (est)

0%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Sanguine News

2022-04-20 - The Regrettes bring sanguine pop, punky candor to 'Further Joy'

The Regrettes bring sanguine pop, punky candor to 'Further Joy'. Cover of The Regrettes' latest album Further Joy. Warner Records/Courtesy. By...

2022-04-13 - Morgan Stanley's Wilson Says the Bond Market and S&P 500 ...

Bond markets and the S&P 500 are too sanguine about the economic outlook, according to Morgan Stanley's chief U.S. equity strategist.

2022-04-06 - Do You Often Feel A Sense Of Longing? You May Have This Personality Type

The purpose of the Bittersweet Quiz (and the Bittersweet book) is to help you assess whether you tend to be more sanguine or bittersweet in...

2013-02-23 - Sanguine Biosciences Raises Seed Funding

Sanguine Biosciences Inc., a Valencia, CA-based biotechnology startup, raised a seed funding of undisclosed amount. Backers included INVENT Ventures and Heliant Ventures. Led by Brian Neman, CEO, Sanguine BioSciences is a biotechnology company that aims to provide transparency throughout the p ...

2013-02-22 - Sanguine BioSciences Finds Seed Funding

Valencia-based Sanguine Biosciences, a startup developing a service around blood sample collection for research and development, said Thursday that it has closed on a seed financing round. Size of the round was not announced. The funding was led by INVENT Ventures and Heliant Ventures. Sanguine ...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$45.7M1549%N/A
#2
$24.6M1548%N/A
#3
$45.7M1548%N/A
#4
$34.7M15415%N/A
#5
$15M154-3%N/A